American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 31, Issue 5 , Pages 368-371 , September 2010

Epistaxis due to Wegener's granulomatosis in a pediatric patient

  • Don Hayes Jr, MD

      Affiliations

    • Department of Pediatrics, University of Kentucky College of Medicine, J410 Kentucky Clinic, Lexington, KY, USA
    • Department of Internal Medicine, University of Kentucky College of Medicine, J410 Kentucky Clinic, Lexington, KY, USA
    • Corresponding Author InformationCorresponding author. Department of Pediatrics, University of Kentucky College of Medicine, J410 Kentucky Clinic, 740 South Limestone Street, Lexington, KY 40536, USA. Tel.: +1 859 257 5536; fax: +1 859 257 1888.
  • ,
  • Joseph A. Iocono, MD

      Affiliations

    • Department of Surgery, University of Kentucky College of Medicine, MS235 Chandler Medical Center, Lexington, KY, USA
  • ,
  • Jeffery S. Bennett, MD

      Affiliations

    • Department of Pediatrics, University of Kentucky College of Medicine, HA415 Chandler Medical Center, Lexington, KY, USA
  • ,
  • David Corey Lachman, MD

      Affiliations

    • Department of Pediatrics, University of Kentucky Pediatric Residency Program, Lexington, KY, USA
  • ,
  • Hubert O. Ballard, MD

      Affiliations

    • Department of Pediatrics, University of Kentucky College of Medicine, MS467 Chandler Medical Center, Lexington, KY, USA

Received 19 April 2009

References 

  1. Bernius M, Perlin D. Pediatric ear, nose, and throat emergencies. Pediatr Clin North Am. 2006;53:195–214
  2. Doyle DE. Anterior epistaxis: a new nasal tampon for fast, effective control. Laryngoscope. 1986;96:279–281
  3. Dedeoglu F, Sundel RP. Vasculitis in children. Rheum Dis Clin North Am. 2007;33:555–583
  4. Gardner-Medwin JM, Dolezalova P, Cummins C, et al. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360:1197–1202
  5. Dolezalová P, Telekesová P, Nemcová D, et al. Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey. J Rheumatol. 2004;31:2295–2299
  6. Wilkinson NM, Page J, Uribe AG, et al. Establishment of a pilot pediatric registry for chronic vasculitis is both essential and feasible: a Childhood Arthritis and Rheumatology Alliance (CARRA) survey. J Rheumatol. 2007;34:224–226
  7. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488–498
  8. Sullivan EJ, Hoffman GS. Pulmonary vasculitis. Clin Chest Med. 1998;19:759–776ix
  9. Stone JH Wegener's Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum. 2003;48:2299–2309
  10. Cotch MF, Hoffman GS, Yerg DE, et al. The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum. 1996;39:87–92
  11. Koldingsnes W, Nossent H. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum. 2000;43:2481–2487
  12. Stegmayr BG, Gothefors L, Malmer B, et al. Wegener granulomatosis in children and young adults. A case study of ten patients. Pediatr Nephrol. 2000;14:208–213
  13. Akikusa JD, Schneider R, Harvey EA, et al. Clinical features and outcome of pediatric Wegener's granulomatosis. Arthritis Rheum. 2007;57:837–844
  14. Gayraud M, Guillevin L, le Toumelin P, et al. French Vasculitis Study Group Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum. 2001;44:666–675
  15. Matteson EL, Gold KN, Bloch DA, et al. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort. Am J Med. 1996;101:129–134
  16. Slot MC, Tervaert JW, Franssen CF, et al. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int. 2003;63:670–677
  17. Booth AD, Almond MK, Burns A, et al. Pan-Thames Renal Research Group Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003;41:776–784
  18. Reinhold-Keller E, Beuge N, Latza U, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum. 2000;43:1021–1032
  19. Bligny D, Mahr A, Toumelin PL, et al. Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients. Arthritis Rheum. 2004;51:83–91

 There are no financial disclosures to report for any author. There has been no financial support in preparation of this report.

☆☆ The authors have no commercial or proprietary interest in any drug, device, or equipment mentioned in this report.

PII: S0196-0709(09)00086-6

doi: 10.1016/j.amjoto.2009.05.001

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 31, Issue 5 , Pages 368-371 , September 2010